Silexion Therapeutics Corp
SLXN9.040USD
-0.240-2.59%
Close 08/04, 16:00（ET）Quotes delayed by 15 min
9.040USD+9.040After-hours (ET)
78.58MMarket Cap
9.50P/E TTM
Silexion Therapeutics Corp
9.040
-0.240-2.59%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
Operating expenses
32.00%1.65M
9.95%1.90M
999.32%8.04M
-2.05%1.39M
54.70%1.25M
254.02%1.73M
208.44%731.00K
800.67%1.41M
130.70%808.00K
--488.11K
--237.00K
--156.99K
--350.24K
R&D expenses
-38.61%590.00K
-30.71%871.00K
501.31%3.22M
-37.98%766.00K
41.12%961.00K
--1.26M
--535.00K
--1.23M
--681.00K
----
----
----
----
Depreciation, depletion, and amortization
-50.00%4.00K
----
120.00%22.00K
-50.00%7.00K
-46.67%8.00K
--6.00K
--10.00K
--14.00K
--15.00K
--0.00
--0.00
--0.00
--0.00
Other operating expenses
----
---13.00K
----
----
----
----
----
----
----
----
----
----
----
Operating profit
-32.00%-1.65M
-9.95%-1.90M
-999.32%-8.04M
2.05%-1.39M
-54.70%-1.25M
-254.02%-1.73M
-208.44%-731.00K
-800.67%-1.41M
-130.70%-808.00K
---488.11K
---237.00K
---156.99K
---350.24K
Net non-operating interest income (expenses)
Non-operating interest income
----
----
-100.00%0.00
-84.62%6.00K
-51.28%19.00K
-96.68%33.00K
-91.92%42.00K
-76.12%39.00K
315.51%39.00K
--992.92K
--520.02K
--163.34K
--9.39K
Non-operating interest expense
----
--24.00K
----
----
----
----
----
----
----
----
----
----
----
Gains from sale of securities
102.83%3.00K
-148.18%-53.00K
9.65%-103.00K
91.08%-44.00K
-402.86%-106.00K
--110.00K
---114.00K
---493.00K
--35.00K
----
----
----
----
Special income (expenses)
2.47%-79.00K
359.55%231.00K
---3.72M
-3300.00%-64.00K
-8200.00%-81.00K
-756.35%-89.00K
-100.00%0.00
-94.50%2.00K
-98.95%1.00K
---10.39K
--9.56K
--36.35K
--95.19K
Income before tax
-22.36%-1.73M
-4.30%-1.75M
-1376.71%-11.86M
20.31%-1.49M
-93.45%-1.42M
-438.58%-1.67M
-374.46%-803.00K
-4470.74%-1.87M
-198.38%-733.00K
--494.41K
--292.58K
--42.69K
---245.66K
Income tax
-100.00%0.00
-83.33%1.00K
-66.67%2.00K
-80.00%2.00K
-50.00%5.00K
--6.00K
--6.00K
--10.00K
--10.00K
----
----
----
----
Income after tax
-21.93%-1.73M
-3.99%-1.75M
-1366.01%-11.86M
20.63%-1.49M
-91.52%-1.42M
-439.80%-1.68M
-376.51%-809.00K
-4494.16%-1.88M
-202.45%-743.00K
--494.41K
--292.58K
--42.69K
---245.66K
Net income from continuous operations
-21.93%-1.73M
-3.99%-1.75M
-1366.01%-11.86M
20.63%-1.49M
-91.52%-1.42M
-439.80%-1.68M
-376.51%-809.00K
-4494.16%-1.88M
-202.45%-743.00K
--494.41K
--292.58K
--42.69K
---245.66K
Other net gains and losses
----
----
--4.00K
----
----
----
----
----
----
----
----
----
----
Net Income attributable to non-controlling interests
----
----
--9.00K
----
----
----
----
----
----
----
----
----
----
Net income attributable to controlling interests
-21.93%-1.73M
-3.99%-1.75M
-1366.01%-11.86M
20.63%-1.49M
-91.52%-1.42M
-439.80%-1.68M
-376.51%-809.00K
-4494.16%-1.88M
-202.45%-743.00K
--494.41K
--292.58K
--42.69K
---245.66K
Net income attributable to common shareholders
-21.93%-1.73M
-3.99%-1.75M
-1366.01%-11.86M
20.63%-1.49M
-91.52%-1.42M
-439.80%-1.68M
-376.51%-809.00K
-4494.16%-1.88M
-202.45%-743.00K
--494.41K
--292.58K
--42.69K
---245.66K
Basic earnings per share
80.48%-0.26
38.95%-0.94
-1180.87%-9.55
20.63%-1.37
-91.52%-1.31
-5001.27%-1.55
-3883.65%-0.75
-60324.74%-1.73
-4038.69%-0.68
--0.03
--0.02
--0.00
---0.02
Diluted earnings per share
80.48%-0.26
38.95%-0.94
-1180.87%-9.55
20.63%-1.37
-91.52%-1.31
-5001.27%-1.55
-3883.65%-0.75
-60324.74%-1.73
-4038.69%-0.68
--0.03
--0.02
--0.00
---0.02
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
